imatinib mesylate has been researched along with Glaucoma, Neovascular in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Angmo, D; Kamble, N; Roop, P; Tomar, AS | 1 |
1 review(s) available for imatinib mesylate and Glaucoma, Neovascular
| Article | Year |
|---|---|
Uncontrolled neovascular glaucoma - an alarming manifestation of chronic myeloid leukemia on imatinib therapy - a case report and review of literature.
Topics: Antineoplastic Agents; Glaucoma, Neovascular; Gonioscopy; Humans; Imatinib Mesylate; Intraocular Pressure; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Middle Aged; Recurrence; Trabeculectomy; Visual Acuity | 2019 |